SPL Medical Announces First Prostate Cancer Metastasis Patient Diagnosed with Ferrotran in Compassionate Use Program

December 24, 2019 — SPL Medical announced today that the first patient has been successfully diagnosed with suspected lymph node metastases of prostate cancer with Ferrotran (Ferumoxtran) at the University Hospital Zurich. This follows approval (Sonderbewilligung acc. to Swiss AMBV) by Swissmedic to Universitätsspital Zurich, Institut für Diagnostische und Interventionelle Radiologie, for…

Read the full article here

Source: Imaging Technology News

Categories: Urology

Tweets with this article

Jelle Barentsz

SPL Medical Announces First Prostate Cancer Metastasis Patient Diagnosed with Ferrotran in Compassionate Use Program https://t.co/fb7YgGXHpg

Update on PI-RADS Version 2.1 Diagnostic Performance Benchmarks for Prostate MRI: Systematic Review and Meta-Analysis | Radiology

Background Prostate MRI for the detection of clinically significant prostate cancer (csPCa) is standardized by the Prostate Imaging Reporting and Data System (PI-RADS), currently in…

Jelle Barentsz August 25, 2024

Grote bestanden versturen gratis | Bestand uploaden | Bestandsoverdracht

Verstuur gratis grote bestanden met TransferXL ✔ zonder registratie ✔ veilig en snel bestanden uploaden ✔ bestandsoverdracht tot 200 GB ✔ via e-mail of link

Jelle Barentsz August 18, 2024

Capturing the Essence of Nature: A Study in Contrast by Jelle Barentsz

Capturing the Essence of Nature: A Study in Contrast by Jelle Barentsz | Category: Fine Art Photography – Nature | European Photography Awards

Jelle Barentsz August 16, 2024

Ferumoxtran-10-enhanced MRI for pre-operative metastatic lymph node detection in pancreatic, duodenal, or periampullary adenocarcinoma

European Radiology – To assess 3-Tesla (3-T) ultra-small superparamagnetic iron oxide (USPIO)-enhanced MRI in detecting lymph node (LN) metastases for resectable adenocarcinomas of the pancreas,…

Jelle Barentsz July 9, 2024

Registration is open! 12th ESUR Prostate MRI

Data Protection InformationResponsible: THEORIA CONGRESOS (Hernández Tena Congresos S.L; Purpose: to provide you with the services you have requested, attend your requests for information and…

Jelle Barentsz February 26, 2024

The association between patient and disease characteristics, and the risk of disease progression in patients with prostate cancer on active surveillance

World Journal of Urology – The objective of this study was to identify and assess patient and disease characteristics associated with an increased risk of…

Jelle Barentsz February 25, 2024

Registration is open! 12th ESUR Prostate MRI

Data Protection InformationResponsible: THEORIA CONGRESOS (Hernández Tena Congresos S.L; Purpose: to provide you with the services you have requested, attend your requests for information and…

Jelle Barentsz February 7, 2024

Quantification and significance of extraprostatic findings on prostate MRI: a retrospective analysis and three-tier classification – Insights into Imaging

Objectives To quantify extraprostatic findings (EPFs) on prostate MRI, estimate the proportion of reported and unreported EPFs, assess their clinical importance, and propose standardized reporting…

Jelle Barentsz December 22, 2023

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

European Radiology – To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to…

Jelle Barentsz November 27, 2023

Visibility of significant prostate cancer on multiparametric magnetic resonance imaging (MRI)—do we still need contrast media?

European Radiology – To assess the visibility of clinically significant prostate cancer (PCA) lesions on the sequences multiparametric MRI of the prostate (mpMRI) and to…

Jelle Barentsz November 27, 2023

Related Articles